Award
Delivery Order #SPE2DR26FMEJ9
Delivery Order for Soliris Vials Under Pharmaceutical IDV with DMS Pharmaceutical
Buyer
Defense Logistics Agency
Award Amount
$20,547.08
Ceiling
$20,547.08
Awarded
February 11, 2026
Period of Performance
Feb 11, 2026 – Mar 05, 2026
Identifier
SPE2DR26FMEJ9
NAICS
424210
This award is a delivery order contract issued under an existing indefinite delivery vehicle (IDV) held by DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical distribution for healthcare programs. The contract procures Soliris 300 mg/30 ml vials, a critical pharmaceutical product used in specialized treatments, thereby supporting government healthcare facilities' medication supply. The delivery order represents a short-term, focused procurement that complements the broader IDV contract aimed at streamlining pharmaceutical supply chains. It was awarded through the established vehicle without additional competitive bidding, leveraging the efficient procurement path of the parent contract. The performance period for this delivery order spans a few weeks, reflecting the timely fulfillment of specific medication needs. This order reinforces continuity and reliability in sourcing essential pharmaceuticals critical to patient care within public sector health initiatives.
Description
4570837674!SOLIRIS 300 MG/30 ML VIAL 30ML